Fatima Cardoso Calls For a Comprehensive European Strategy on Genetic and Genomic Testing for Breast Cancer – TBCT
Transforming Breast Cancer Together shared a post on LinkedIn:
“Belgium’s Cancer Diagnostics Lag Behind
Belgium is falling behind in adopting advanced cancer diagnostics, particularly in the reimbursement of biomarker tests—a key tool for personalised cancer treatment.
A recent Euractiv article highlights the systemic hurdles in integrating these innovations into clinical practice. This delay not only affects patient outcomes but also reflects broader challenges in aligning healthcare systems with cutting-edge science.
Dr. Fatima Cardoso, a member of TBCT, calls for a comprehensive European strategy on genetic and genomic testing for breast cancer, urging the European Commission to support standardised access across member states.
It’s time for policy reform to ensure timely, equitable access to life-saving diagnostics.”
More posts featuring Fatima Cardoso.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023